The guidelines, developed by the Royal Children’s Hospital (RCH) Gender Service and endorsed by the Australian Professional Association for Trans Health (AusPATH), are intended to provide a clinical framework for supporting trans and gender diverse children and adolescents across Australia.
They are directed at health professionals — paediatricians, endocrinologists, psychiatrists, psychologists, GPs, nurses, fertility specialists — with the aim of ensuring “affirming and consistent” care. The guidelines are not school or corrections policies, though they anticipate liaison with schools and other institutions.
Guiding Principles
The document is built around a set of clinical values:
- Individualised Care: each child’s needs are considered unique, with no one-size-fits-all model.
- Affirmation: clinicians are expected to use preferred names, pronouns, and to support social transition where requested.
- Avoiding Harm: the guideline states that withholding gender-affirming treatment is not neutral, but may itself cause psychological harm.
- Multidisciplinary Oversight: emphasises coordinated care between mental health, medical, and allied health professionals.
Clinical Pathways
The guideline outlines the process after a diagnosis of gender dysphoria:
- Assessment: conducted by a mental-health clinician to confirm diagnosis, assess comorbidities, and evaluate decision-making competence.
- Puberty Suppression: offered from Tanner stage 2 of puberty, if diagnosis is confirmed and fertility counselling provided. Bone health must be monitored, though long-term risks are acknowledged as uncertain.
- Gender-Affirming Hormones: available in later adolescence, with team consensus and informed consent. Some changes are irreversible, so fertility preservation counselling is mandatory.
- Surgery: chest surgery may be considered for some adolescents; genital surgery is usually delayed until adulthood.
Consent and Legal Safeguards
- Informed Consent: adolescents must demonstrate competence (“Gillick competence”), or parents/guardians provide consent.
- Court Involvement: if there is dispute about competence, diagnosis, or treatment, court authorisation is required.
- Fertility Counselling: mandatory prior to any medical intervention.
Evidence Base and Gaps
The guideline acknowledges:
- Recommendations are based largely on clinician consensus, WPATH guidelines, and observational studies, not high-quality trials.
- Long-term impacts on fertility, bone health, and psychosocial outcomes remain unclear.
- More robust research is urgently needed to strengthen the evidence base.
Treatment over Causation
A striking feature is that the AusPATH / RCH standards do not explore the causes of gender dysphoria. Instead:
- Gender dysphoria is treated as a given condition requiring affirmation.
- Co-existing conditions (anxiety, depression, autism, trauma) are acknowledged but not explored as potential causes.
- The focus is on treatment, affirmation, and harm-reduction, not understanding why a child develops gender dysphoria.
This reflects an affirmation-first model, in contrast to clinical approaches that investigate underlying developmental, psychological, or social drivers.
Policy Implications for Women and Girls
- School involvement: clinicians are advised to liaise with schools to support social transition. This directly influences policies on bathrooms, changerooms, and sports, with consequences for girls’ privacy and safety.
- Single-sex spaces: while not directly discussed, recommendations that support social transition and affirmation can lead to policy changes that erode women-only and girl-only provisions.
- Safeguarding gaps: by prioritising affirmation over causation, the guidelines may overlook risks to both the child and to others, particularly in shared spaces.
Comparison with the Cass Review
| Aspect | AusPATH / RCH Guidelines | Cass Review |
|---|---|---|
| Focus | Affirmation, access to treatment, reducing harm | Caution, holistic assessment, safeguarding |
| Causation | No exploration of causes; dysphoria treated as a given | Explicitly states causes are unknown; urges exploration of psychological, developmental, and social factors |
| Comorbidities | Acknowledged but treated as parallel issues | Emphasised; autism, trauma, and mental illness seen as potentially significant in distress presentation |
| Treatment Approach | Puberty blockers, hormones, sometimes surgery, with consent safeguards | Recommends restraint and careful, multidisciplinary assessment before medicalisation |
| View on Affirmation | Withholding affirmation seen as harmful | Warns against “concretising” identity too early |
| Evidence Base | Relies on consensus, WPATH, observational studies | Concludes evidence for puberty blockers/hormones in youth is weak and uncertain |
| Policy Direction | Supports affirming care, urges institutions to adapt | Calls for a new, evidence-led national service model with cautious, research-informed practice |
Conclusion
The AusPATH / RCH Gender Standards are a clinical framework built on affirmation-first principles, aiming to reduce distress and improve access to care for trans youth. However, they avoid examining the causes of gender dysphoria and treat it as a condition to be affirmed and treated, rather than investigated.
By contrast, the Cass Review in the UK takes a more cautious, safeguarding-first approach, highlighting the uncertainty of causes, the high rates of comorbidities, and the limited evidence for medical interventions in youth. It recommends slower, holistic assessment and warns against early affirmation that may lock children into a path without exploring why they are distressed in the first place.